Role of Whole-Body Diffusion-Weighted MR in Assessment of Neoplastic Leisons

Size: px
Start display at page:

Download "Role of Whole-Body Diffusion-Weighted MR in Assessment of Neoplastic Leisons"

Transcription

1 Med J Cairo Univ, Vol 81, No 2, March: , 2013 wwwmedicaljournalofcairouniversitycom Role of Whole-Body Diffusion-Weighted MR in Assessment of Neoplastic Leisons NAGUI M ABDELWAHAB, MD; MARYSE Y AWADALLAH, MD and AYA M BASSAM, MSc The Department of Radiodiagnosis, Faculty of Medicine, Cairo University Abstract Purpose: The aim of this work is to evaluate the value of whole body diffusion weighted imaging (DWI) in detection of metastatic bone disease, using bone scintigraphy as comparison Patients and Methods: Fifteen patients (5 males 10 females), with known primary malignant tumor (confirmed histologically) underwent both whole body MR1 including diffusion weighted whole body imaging with background body signal suppression (DWIBS) and skeletal scintigraphy to detect metastasis Results: All extraosseous lesions (detected by other modalities as computed tomography and ultrasound) were detected and most of bone lesions (detected by bone scan) were also detected Conclusion: We concluded that WB-MRI that included DWI holds great promise, and has shown utility in the identification of both bony and visceral metastases However, more optimization is required for WB-DWI to become a routine screening tool, and large-scale studies are needed to fully gauge its impact in oncology Key Words: DWIBS Whole body MRI DWI Neoplastic lesions Metastatic lesions Introduction DIFFUSION-WEIGHTED sequence (DWI) of the entire body is a new promising technique feasible to evaluate multifocal disease [ii Technological advances and the development of the concept of diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) have opened the path for routine clinical wholebody DWI Whole-body DWI allows detection and characterization of both oncological and nononcological lesions throughout the entire body [2] Diffusion-weighted imaging provides important information about the movement and functional status of the microenvironment of water in tissue Correspondence to: Dr Maryse Y Awadallah, The Department of Radiodiagnosis, Faculty of Medicine, Cairo University Changes in diffusion of water within pathological tissue may occur before they are seen on standard MR imaging [3] There is growing interest in the application of DWI for the evaluation of the patient with cancer DWI measurements are quick to perform (typically 1-5 minutes) Practical implementation of whole body DWI, using the DWIBS concept, is relatively easy, since it can be performed on most modem MRI scanners and does not require any contrast agent administration Furthermore, compared to SPECT/CT and PET CT, MRI scanners are more widely available and whole body DWI is less expensive [4] DWI is a powerful imaging tool that provides unique information related to tumor cellularity and the integrity of the cellular membrane The technique can be applied widely for tumor detection, tumor characterization and monitoring of tumor response [5] WB-MR imaging using DW sequences is more sensitive than scintigraphy, supplying additional information on non bone-related lesions Whole body diffusion imaging technique might help the clinicians to accept the whole body MR imaging as a routine method for the diagnostic work-up and consider it as an alternative to bone scan and/or PET ill Patients and Methods Fifteen patients (5 males and 10 females), referred to the Radiology department of Kasr Al- Ainy Hospitals from the outpatient clinic of the Clinical Oncology department, their ages ranged between 34 to 70 years, with known primary malignant tumor (confirmed histologically) underwent whole body MRI including diffusion weighted whole body imaging with back ground body signal 213

2 214 Role of Whole-Body Diffusion-Weighted MR suppression (DWIBS), skeletal scintigraphy and any other modality to detect extraosseous metastases as computed tomography and ultrasound 8 patients, breast carcinoma; 2 prostate carcinoma; 2 bladder carcinoma; one each, thyroid malignancy, bronchogenic carcinoma and endometrial carcinoma The number of metastatic lesions detected in the 15 patients was categorized into bony metastatic lesions (detected by bone scan) and extra-osseous metastatic lesions (detected by other modalities as computed tomography, ultrasound and other MRI sequences) These findings were then compared to the findings of whole body diffusion MRI Inclusion criteria: Pathologically diagnosed primary tumours with bone and/or soft tissue metastases Exclusion criteria: Claustrophobia or other contraindications to MRI MR technique: All MR studies were performed on a 15-T MR imaging unit (Intera, Philips medical system) Patients were placed in the supine and feet-first position on the extended patient table platform, allowing covering of most of the body of adult patients from the head to the tibia DWIBS pulse sequence: The DWIBS were acquired axially with the Q body coil under free breathing conditions using an EPI single-shot pulse sequence The gradients of the DWI were applied along the X, Y and Z axes before and after a 180 inversion pre-pulse to obtain fat-saturated, isotropic images with DWI sensitivity using the following parameters for a single stack: B-value 1,000mm2/s, TR (Repetition time)/te (Echo time)/ir (Inversion recovery) (8773/70/180ms); field of view (FOV): Right/left 350mm, anterior/posterior 258mm, feet/head 420mm; slice thickness 6mm; size of reconstructed voxel was 156 x 156x6mm In all patients, five of the above-described stacks were acquired one after the other in order to image from the head to the middle of the tibia Overall, the required imaging time corresponded to about 25min Other pulse sequences parameters: The whole body MRI also included Tl, T2 and STIR pulse sequences with the following parameters Table (1): MRI parameters in whole body Tl, T2 and STIR Parameters T1 T2 STIR TR TE FOV: Right/Left Anterior/Posterior Feet/Head Slice thickness 8mm 8mm 8mm Gap l mm lmm lmm Skeletal scintigraphy: Standard skeletal radionuclide scintigraphy was performed within a month from WB MRI The examination was performed 3 hours after injection of 15-20mCi ( MBq) of 99TC-MDP Images were collected using a dual-head whole-body scanner with a high-resolution, low-energy collimator Qualitative image analysis: The DW images have to be processed on the workstation The 3D data sets from the different axial series are combined, reformatted and viewed along any axis as maximum intensity projections as a unique series The multiplanar reformatted images can be displayed as a whole-body image in the coronal plane Inverted black-and-white gray scale source MR DWIBS images (b=1,000mm2/s) were analyzed on the workstation which seem more familiar to clinicians, as they have some resemblance to the usual displays seen in scintigraphy or in PET Qualitative analysis can be performed directly from the reformatted view on the three planes Signals from normal tissue such as blood vessels, fat, muscle, and bowel are suppressed However, other normal structures such as the spleen, prostate, testes, ovaries, endometrium, and the spinal cord remain visible The lesions were only categorized according to the subjectively rated signal pattern, signal intensity and morphology without taking into account the apparent diffusion coefficients, which were not quantified Malignant lesions generally exhibit considerably greater signal intensities and variability on their profile than benign ones In addition to diffusion-weighted sequence, T1- weighted, T2-weighted and STIR images were also evaluated to combine information, to accurately detect pathology and rule out artifacts from the diffusion-weighted sequence series The skeletal scintigrams were also analyzed; the increased uptake pattern of the identified lesions

3 Nagui M Abdelwahab, et al 215 was rated according to the clinical experience No quantitative measurements were considered Statistical analysis: Data were statistically described in terms of mean±standard deviation (±SD), median and range, or frequencies (number of cases) and percentages when appropriate All statistical calculations were done using computer programs SPSS (Statistical Package for the Social Science; SPSS Inc, Chicago, IL, USA) version 15 for Microsoft Windows Number of cases gib&lif 1 Breast carcinoma (533)% 0 Prostatic carcinoma (133) O Bladder carcinoma (133) s Bronchogenic carcinoma (67) Thyroid lymphoma (67) 0 Endometrial carcinoma (67) Fig (1): Classification of 6 pathological entities which were examined in the 15 cases Resufts This study included 15 patients; 5 males, 10 females with age range from 33 years to 70 years (mean age 595 years), suffering from known primary malignant tumor with metastases Table (2): Number and percentage of the cases who had pure bone metastases and mixed bone and extraosseous metastases Type of metastases Pure bone metastases Number of cases Percent (%) 667% 333% 100% Table (3): Number and percentage of bony metastatic lesions detected by whole body DWI as compared to bone scan Item Mixed bone and extraosseous Total metastases Bone scan WB DWI Number of bony metastatic lesions Percent (%) 100% 947% The total number of bony metastatic lesions which was diagnosed in the 15 cases was 113 lesions, while the total number which was diagnosed by WB DWI was 107 lesions, representing 947% The WB DWI showed all the extraosseous lesions detected by other modalities as computed tomography, ultrasound and other MRI sequences Also, it showed the bony lesions detected by bone scan in the following sites: Vertebra, sternum, femur, acetabulum, humerus, scapula, tibia, shoulder, pelvic bone, greater trochanter, clavicle, coracoid process and sacrum On the other hand, lesions in skull and lateral condyle of femur and one rib lesion were missed The sensitivity of WB DWI in detecting metastatic bony lesions was 100% with positive predictive value=947% While the sensitivity of WB DWI in detecting metastatic ribs lesions was 100% with positive predictive value=952% The sensitivity of WB DWI in detecting extraosseous lesions was 100% with positive predictive value=100% Table (4): Sites, number and percentage of bone metastatic lesions detected by whole body DWI as compared to bone scan Site Bone scan WB DWI Percentage of lesions detectedby WB DWI as compared to bone scan (%) Vertebra Strenum Ribs Femur Acetabulum Humerus Scapula Tibia Skull Shoulder Pelvic bone Lateral condyle 1 o o Greater trochanter Clavicle Coracoid process Sacrum Table (5): Sites, number and percentage of soft tissue metastatic lesions detected by whole body DWI as compared to other modalities as computed tomography, ultrasound and other MRI sequences Site Liver Lung Kidney Suprarenal glands Lymph nodes Percentage of lesions Other WB detected by WB DWI modalities DWI as compared to bone scan (%)

4 216 Role of Whole-Body Diffusion-Weighted MR --ro 4 I s i 0 1 # I r t t LA i a I L a (Fig 2) tvp 4 I' 1 lipqr wit N Misr % # (Fig 4) Figs (2-5): A case of bronchogenic carcinoma in a male patient 51 years old, referred to us complaining of left lower limb pain Bone scan showing single osseous metastatic lesion at the lower end of left femur (Fig 2) WB DWI showing metastatic osseous lesion, in addition to a malignant lesion is seen in the right lung (the primary bronchogenic carcinoma) and mediastinal lymph nodes metastases (Fig 3) The source axial image (b-value 1000) showing the primary lung lesion (Fig 4) WB MRI (STIR and T1) showing metastatic lesion in the lower end of left femur, primary right bronchogenic carcinoma and mediastinal lymph node (Fig 5a,b) (Fig 5A) (Fig 5B) (Fig 6) 4 Tir 1-11rNi os 471" L? 14 t I -- - e infii c et "If'tf ; 1 Ir 'II -!4P ik 4,, EA '1! IR rca-,, 1 kr* ' ' ' 7 r 4, Kla! el it Att/,- 1eti, - i ) t 1 ii 4 % - (Fig 7) $ 4 ' Ai 111: ' 0, 01 el 11 6 Iti `-- i ik Pi? iii A L, ' i - 4, il { 2 III Ot -t,f iiikt II ' M 4e A 4 T 1 IN C 2 i OP - Pifit I % L -:tr" I( 1 i- 1 i llit A,, 7 7 ) ri ill -* ip bii, ' ṭrio t

5 I Nagui M Abdelwahab, et al 217 (Fig 9B) Figs (6-10): A case of pathologically proven thyroid lymphoma, with thyroidectomy, in a female patient 64 years old Bone scan (posterior view) showing metastatic lesions at sacrum, DV2, 7 and 8 and posterior segment of left 7th rib (Fig 6) WB DWI showing metastatic lesions at sacrum, DV2, 7 and 8, posterior segment of left 7th rib, right axillary lymph node, liver and bilaterally enlarged kidneys with multiple infiltrations (Fig 7) The source axial image (ADC=10, it was stated that if it is less than 12 in liver lesions then it is malignant if not then it's benign lesion) showing multiple liver metastases (Fig 8) The source axial image (b-value 1000) and (ADC) showing bilateral renal infiltrations (the bright lesions seen in diffusion images became dark in ADC images) (Fig 9a,b) WB MRI (DWI and STIR) showing axillary lymph node (LN) affection (Fig 10) - a MEM (Fig 11) (Fig 12) 0 j, 3,' _,t,, 1-i 49 A I I r S _ #L1% 400, :_,Ai,4wi A dr, 411 L 1 7 T 4 rf- Oh, ;t A -is- -is_a Li 70% 4,0 1, , _, E: I - - A Jet,,k S 4# 01 0 (Fig 13A) (Fig 13B) (Fig 13C)

6 218 Role of Whole-Body Diffusion-Weighted MR Figs (11-14 ): A case of cancer prostate in a male patient 70 years old, referred to us for follow-up Bone scan showing multiple osseous lesions at right scapula, sternum, right 9th and 10th ribs, DV 10 and its costovertebral junction and left greater trochanter (Fig 11) WB DWI: The primary malignant lesion is seen (prostatic carcinoma), in addition to multiple metastatic lesions in the right scapula, left humerus, sternum, left 9th rib, right 9th 10thand 12th ribs, DV 10 and its costovertebral junction, left greater trochanter, bilateral suprarenal glands metastases and right apical lung metastasis (Fig 12) The source axial image (b-value 1000) showing bilateral suprarenal glands infiltrations, bilateral 9th ribs metastases and right 10th rib and 10th dorsal vertebra metastases (Fig 13 a,b,c) WB MRI (DWI and T1) showing right 12th rib metastases (Fig 14) (Fig 14) Discussion The development of skeletal or organ metastases is often difficult to detect and usually not found until clinical symptoms present or is discovered during tumor staging with radiological imaging If metastatic disease is present, the usual sites are in bones, liver, brain, and lung [6] Determination of metastatic disease is accomplished using radiological imaging, such as plain film X-ray, Tc99m bone scintigraphy, computed tomography (CT), positron emission tomography (PET), magnetic resonance imaging (MRI) [7] Indeed, these radiological procedures are the cornerstone for the detection and staging of metastatic lesions, and, if possible, classifying the type of lesion as well as the extent and localization of metastatic sites However, until recently, most sensitive radiological procedures were limited to only "regional" or "local" coverage and could not interrogate the full body [6] Bone is a most common site of distant metastasis (50-70%), especially in patients with prostate and breast cancer [8] Bone metastases causes much of the morbidity and disability in patients suffering from tumors The standard procedure for visualizing bone metastases in patients with a malignant underlying disease is skeletal scintigraphy However, in several studies whole body magnetic resonance imaging (WB-MRI) has shown better results than skeletal scintigraphy [9] Whole body DWI can be used to detect metastases because DWI is sensitive to the random (Brownian) motion of water molecules In biologic tissue, the presence of impeding barriers (eg, cell membranes, fibers, and macromolecules) interferes with the free displacement (diffusion) of water molecules Consequently, the signal intensity in DWI depends on the separation and permeability of these impeding boundaries Rol The degree of restriction to water diffusion in biologic tissue is inversely correlated to the tissue cellularity and the integrity of cell membranes The motion of water molecules is more restricted in tissues with a high cellular density associated with numerous intact cell membranes (eg, tumor tissue) Diffusion-weighted imaging (DWI) is increasingly applied in the evaluation of cancer patients [iii The principle is that tumors with high cellularity have restricted diffusion of water molecules, which results in higher signal intensity than the surrounding normal tissue [12] In this study the lesions were classified into two main groups; bone metastases (113 lesions) and soft tissue metastases (23 lesions); we used bone scan for detecting bone metastases and other radiological modalities as computed tomography, ultrasound and other MRI sequences to detect extraosseous metastases In our study whole body diffusion MRI was capable to detect all extraosseous lesions (23 lesions) and almost all bony lesions (107 lesions) The missed lesions were 4 lesions in the skull, one lesion in the rib and one lesion in the lateral condyle of the femur In our study according to the sites of the disease, WB DWI is capable for detecting all lesions in the spine, sternum, femur, humerus, scapula, tibia,

7 Nagui M Abdelwahab, et al 219 shoulder and pelvis detected by bone scan We found that whole-body DWI failed to detect a few lesions in the skull and ribs, as have other studies [91 Sakurada et al, 2009 suggested that the limitation in detecting ribs lesions is due to artifacts that are related to pulsation and breathing in the thorax, which make examination of the ribs, sternum and scapula more difficult [13] The reason for missed lesions in the skull is unclear, but may be induced by the interference of high signal in brain [14] It was stated that the normal adult bone marrow distribution becomes established by 25 years of age and that yellow bone marrow has low water content (10%-20%), which results in decreased signal intensity on DW images On the other hand, red bone marrow has increased cellularity and water content (40%-60%), thus resulting in higher signal intensity on DW images There are variable amounts of red bone marrow atrophy and trabecular bone loss after 40 years of age, particularly in women (possibly related to estrogen deficiency and osteoporosis, resulting in increased adiposity, which thus lowers the signal intensity of bone marrow on whole-body DW images as age increases This may explain why in our study the lateral condyle metastatic lesion detected by bone scan was missed by WB DWI in the female patient aged 38 years old [15-18] In our study whole body DWI also detected 2 rib lesions missed by bone scan which were found in retrograde analysis of the bone scan to show very faint tracer uptake, Figs (11-14 ) One of the potential powerful tools of this new whole body sequence is that it also provides additional information of the extraskeletal areas For this reason the technique can be applied for extraskeletal tumor detection and characterization [19] As for soft tissue lesions in our study all lesions were detected by whole body DWI which include liver, lung, kidneys, lymph nodes and suprarenal glands but for lymph nodes whole body MRI using other sequences (T1, T2 and STIR) were needed to ensure their presence especially for mediastinal lymph node Figs (2-5) It was stated that this is due to signal loss and artifacts due to severe tissue motion [13,20] Nevertheless, MRI is a versatile imaging modality, and the addition of other sequences may improve the evaluation of the mediastinal lymph nodes One of the cases was referred to us as query thyroid malignancy Bone scan revealed multiple bony metastatic lesions Whole body diffusion MRI detected the same bony lesions and in addition it showed infiltrations of both kidneys, liver and axillary lymph node raising the suspicion of lymphoma Biopsy was then taken from the thyroid gland and it was proven to be thyroid lymphoma Figs (6-10) Initial studies describing DWWB MR imaging have focused on the detection of osseous metastases in patients with primary malignancies that had the potential to metastasize to the skeletal system [121 Other recently preliminary results of DWWB MR imaging have demonstrated the additional value of this sequence, comparable to skeletal scintigraphy to detect bone metastases, related to wholebody MR imaging protocol without DW images Whole-body MR with DW imaging had a sensitivity of 96% for metastatic bone tumor where WBMR imaging without DW imaging had a sensitivity of 88% [21] In our study, the sensitivity of WB DWI in detecting metastatic bony lesions was 100% with positive predictive value=947% While the sensitivity of WB DWI in detecting metastatic ribs lesions was 100% with positive predictive value =952% The difference may be due to the small sample size The sensitivity of WB DWI in detecting extraosseous lesions was 100% with positive predictive value=100% This study shows that whole body DWIBS can discover both bone and extraosseous metastases The evidence is that in patients with lmown primary malignancy with proved metastases by other modalities were almost all detected by whole body DWIBS Limitations: Although whole body DWI reveals excellent clinical value, there are still some limitations of our study: The sample size is not large enough for powerful conclusion Furthermore, we were unable to perform a biopsy of all skeletal metastases determined in routine examinations Another limiting factor was the lack of a true gold standard The standard of reference we chose was, however, the most effective method to determine lesions Recommendations: The question of whether besides signal enhancement, quantitative assessment using the ADC values as well would further improve the results, possibly with threshold values between malignant and benign metastatic lesions, should be addressed in future studies Larger studies using this WB DWI

8 220 Role of Whole -Body Diffusion - Weighted MR sequence should be performed, and especially comparing with other whole-body techniques such as PET Conclusion: The introduction of whole-body MRI allows for rapid imaging of the whole body with high spatial resolution and has the potential to evaluate skeletal and visceral metastatic regions throughout the body Overall, DWIBS is an interesting new technique, the ability to show both bone and soft tissue metastases in one examination is the real temptations to use this technique The results of our study showed that DWI of the whole body is a competitive promising technique that can give a quick screening for patients with malignancy and suspected metastatic deposits Further refining of this technique is expected in the future to improve the positive predictive value which is (at the current study) considered real challenge for further improvement of this technique References 1- JOAN C VILANOVA and JOAQUIM BARCELO: Diffusion-weighted whole-body MR screening European Journal of Radiology, 67: , THOMAS C KWEE, TARO TAKAHARA, REIJI OCHI- AI, KAZUHIRO KATAHIRA, MARC VAN CAUTEREN, YUTAKA IMA, RUTGER AJ NIEVELSTEIN and PE- TER R LUIJTEN: Whole-body diffusion-weighted magnetic resonance imaging European Journal of Radiology, 70: , LE BIHAN D: Molecular diffusion nuclear magnetic resonance imaging Magn Reson Q, 7: 1-30, DELFAUT EM, BELTRAN J, JOHNSON G, ROUSSEAU J, MARCHANDISE X and COTTEN A: Fat suppression in MR imaging: Techniques and pitfalls Radiographics, 19: , DOW-MU KOH1,2 and DAVID J COLLINS1,2: Diffusion-weighted MRI in the body: Applications and challenges in Oncology American Journal of Roentgenology, 188: , JACOBS MA, PAN L and MACURA KJ: Whole-body diffusion weighted and proton imaging: A review of this emerging technology for monitoring metastatic cancer Semin Roentgenol, 44 (2): , HAMAOKA T, MADEWELL JE, PODOLOFF DA, HORTOBAGYI GN and UENO NT: Bone imaging in metastatic breast cancer J Clin Oncol, 22 (14): , COLEMAN RE: Clinical features of metastatic bone disease and risk of skeletal morbidity Clin Cancer Res, 12: , GHANEM N, LOHRMANN C, ENGELHARDT M, et al: Whole-body MRI in the detection of bone marrow infiltration in patients with plasma cell neoplasms in comparison to the radiological skeletal survey Eur Radiol, 16: , KWEE TC, TAKAHARA T, OCHIAI R, KOH D, OHNO Y, NAKANISHI K, NIWA T, CHENEVERT T, LUIJTEN P and ALAVI A: Complementary Roles of Whole-Body Diffusion-Weighted MRI and 18 F-FDG PET: The State of the Art and Potential Applications J Nucl Med, 51: , KOH DM and COLLINS DJ: Diffusion-Weighted MRI in the Body: Applications and Challenges in Oncology AJR, 188: , TAKAHARA T, IMAY Y, YAMASHITA T, YASUDA S, NASU S and VAN CAUTEREN M: Diffusion weighted whole body imaging with background body signal suppression (DWIBS): Technical improvement using free breathing, STIR and high resolution 3D display Radiat Med, 22: , SAKURADA A, TAKAHARA T, KWEE TC, et al: Diagnostic performance of diffusion weighted magnetic resonance imaging in esophageal cancer Eur Radiol, 19: , XU X, MA L, ZHANG JS, CAI YQ, XU B, CHEN LQ, SUN F and GUO XG: Feasibility of whole body diffusion weighted imaging in detecting bone metastasis on 30T MR scanner Chin Med Sci J, 23 (3): , HWANG S and PANICEK DM: Magnetic resonance imaging of bone marrow in oncology, Part 1 Skeletal Radiol, 36 (10): , GOODSITT MM, HOOVER P, VELDEE MS and HSUEH SL: The composition of bone marrow for a dual-energy quantitative computed tomography technique A cadaver and computer simulation study Invest Radiol, 29 (7): , SCHELLINGER D, LIN CS, FERTIKH D, et al: Normal lumbar vertebrae: Anatomic, age, and sex variance in subjects at proton MR spectroscopy-initial experience Radiology, 215 (3): , SYED FA, OURSLER MJ, HEFFERANM TE, PETER- SON JM, RIGGS BL and KHOSLA S: Effects of estrogen therapy on bone marrow adipocytes in postmenopausal osteoporotic women Osteoporos Int, 19 (9): , VILANOVA JC and BARCELO J: Diffusion-weighted whole-body MR screening European Journal of Radiology, 67: , KOH DM, BROWN G, RIDDELL A M, et al: Detection of colorectal hepatic metastases using MnDPDP MR imaging and diffusion-weighted imaging (DWI) alone and in combination Eur Radiol, 18: , NAKANISHI K, KOBAYASHI M, TAKAHASHI S, et al: Whole body MRI for detecting metastatic bone tumor: Comparison with bone scintigram Magn Reson Med Sci, 4: 11-17, 2005

Prof. Dr. NAGUI M. ABDELWAHAB,M.D.; MARYSE Y. AWADALLAH, M.D. AYA M. BASSAM, Ms.C.

Prof. Dr. NAGUI M. ABDELWAHAB,M.D.; MARYSE Y. AWADALLAH, M.D. AYA M. BASSAM, Ms.C. Role of Whole-body Diffusion MR in Detection of Metastatic lesions Prof. Dr. NAGUI M. ABDELWAHAB,M.D.; MARYSE Y. AWADALLAH, M.D. AYA M. BASSAM, Ms.C. Cancer is a potentially life-threatening disease,

More information

Whole Body MRI. Dr. Nina Tunariu. Prostate Cancer recurrence, progression and restaging

Whole Body MRI. Dr. Nina Tunariu. Prostate Cancer recurrence, progression and restaging Whole Body MRI Prostate Cancer recurrence, progression and restaging Dr. Nina Tunariu Consultant Radiology Drug Development Unit and Prostate Targeted Therapies Group 12-13 Janeiro 2018 Evolving Treatment

More information

Abdominal applications of DWI

Abdominal applications of DWI Postgraduate course, SPR San Antonio (Texas), May 14-15, 2013 Abdominal applications of DWI Rutger A.J. Nievelstein Wilhelmina Children s s Hospital, Utrecht (NL) Outline What is DWI? How to perform? Challenges

More information

Case Reports: Tumor Detection by Diffusion-Weighted MRI and ADC-Mapping with Correlation to PET/CT Results

Case Reports: Tumor Detection by Diffusion-Weighted MRI and ADC-Mapping with Correlation to PET/CT Results Case Reports: Tumor Detection by Diffusion-Weighted MRI and ADC-Mapping with Correlation to PET/CT Results Matthias Philipp Lichy, M.D.; Philip Aschoff, M.D.; Christina Pfannenberg, M.D.; Schlemmer Heinz-Peter,

More information

ORIGINAL ARTICLE ABSTRACT

ORIGINAL ARTICLE ABSTRACT ORIGINAL ARTICLE 99m Tc MDP Bone Scan in Lung Cancer: Predilection Sites for Metastasis Shamim M F Begum, Zeenat Jabin, Rahima Perveen, Nasreen Sultana, Laila S Banu National Institute of Nuclear Medicine

More information

Emerging Referral Patterns for Whole-Body Diffusion Weighted Imaging (WB-DWI) in an Oncology Center

Emerging Referral Patterns for Whole-Body Diffusion Weighted Imaging (WB-DWI) in an Oncology Center Emerging Referral Patterns for Whole-Body Diffusion Weighted Imaging (WB-DWI) in an Oncology Center Poster No.: C-1296 Congress: ECR 2014 Type: Scientific Exhibit Authors: G. Petralia 1, G. Conte 1, S.

More information

primary (CUP) syndrome

primary (CUP) syndrome Role of whole body magnetic resonance imaging with diffusion weighted imaging sequences (DWIBS) vs computed tomography-positron emission tomography (CTPET) in evaluation of patients with carcinoma of unknown

More information

PET-MRI in malignant bone tumours. Lars Stegger Department of Nuclear Medicine University Hospital Münster, Germany

PET-MRI in malignant bone tumours. Lars Stegger Department of Nuclear Medicine University Hospital Münster, Germany PET-MRI in malignant bone tumours Lars Stegger Department of Nuclear Medicine University Hospital Münster, Germany Content From PET to PET/MRI General considerations Bone metastases Primary bone tumours

More information

Bone PET/MRI : Diagnostic yield in bone metastases and malignant primitive bone tumors

Bone PET/MRI : Diagnostic yield in bone metastases and malignant primitive bone tumors Bone PET/MRI : Diagnostic yield in bone metastases and malignant primitive bone tumors Lars Stegger, Benjamin Noto Department of Nuclear Medicine University Hospital Münster, Germany Content From PET to

More information

Utility of ADC Measurements in the Discrimination between Benign and Lymphomatous Abdomino-Pelvic Lymph Nodes

Utility of ADC Measurements in the Discrimination between Benign and Lymphomatous Abdomino-Pelvic Lymph Nodes Med. J. Cairo Univ., Vol. 84, No. 2, September: 1-7, 2016 www.medicaljournalofcairouniversity.net Utility of ADC Measurements in the Discrimination between Benign and Lymphomatous Abdomino-Pelvic Lymph

More information

Monitoring bony metastases response with diffusion MRI

Monitoring bony metastases response with diffusion MRI Monitoring bony metastases response with diffusion MRI Anwar Padhani MD Mount Vernon Hospital Cancer Centre London, UK Objectives To illustrate the potential of whole body DWI in the therapy response assessment

More information

FieldStrength. Leuven research is finetuning. whole body staging

FieldStrength. Leuven research is finetuning. whole body staging FieldStrength Publication for the Philips MRI Community Issue 40 May 2010 Leuven research is finetuning 3.0T DWIBS for whole body staging The University Hospital of Leuven is researching 3.0T whole body

More information

Whole-body MRI including diffusion-weighted imaging compared to CT for staging of malignant melanoma

Whole-body MRI including diffusion-weighted imaging compared to CT for staging of malignant melanoma Upsala Journal of Medical Sciences. 2013; 118: 91 97 ORIGINAL ARTICLE Whole-body MRI including diffusion-weighted imaging compared to CT for staging of malignant melanoma FIRAS MOSAVI 1, GUSTAV ULLENHAG

More information

Role of MRI Diffusion in Assessment of Mediastinal Lymphadenopathy

Role of MRI Diffusion in Assessment of Mediastinal Lymphadenopathy Med. J. Cairo Univ., Vol. 85, No. 3, June: 925-931, 2017 www.medicaljournalofcairouniversity.net Role of MRI Diffusion in Assessment of Mediastinal Lymphadenopathy YOUSSRIAH Y. SABRI, M.D.*; MARIAN FAYEK,

More information

Recommendations for cross-sectional imaging in cancer management, Second edition

Recommendations for cross-sectional imaging in cancer management, Second edition www.rcr.ac.uk Recommendations for cross-sectional imaging in cancer management, Second edition Musculoskeletal tumours Faculty of Clinical Radiology www.rcr.ac.uk Contents Primary bone tumours 3 Clinical

More information

FOR CMS (MEDICARE) MEMBERS ONLY NATIONAL COVERAGE DETERMINATION (NCD) FOR MAGNETIC RESONANCE IMAGING:

FOR CMS (MEDICARE) MEMBERS ONLY NATIONAL COVERAGE DETERMINATION (NCD) FOR MAGNETIC RESONANCE IMAGING: National Imaging Associates, Inc. Clinical guidelines BONE MARROW MRI Original Date: July 2008 Page 1 of 5 CPT Codes: 77084 Last Review Date: September 2014 NCD 220.2 MRI Last Effective Date: July 2011

More information

Imaging of bone metastases

Imaging of bone metastases Imaging of bone metastases Antoine Feydy Service de Radiologie B Hôpital Cochin APHP Université Paris Descartes antoine.feydy@aphp.fr MEXICO 2016 INTRODUCTION Diagnostic Imaging Imaging Modalities Strengths,

More information

MR Tumor Staging for Treatment Decision in Case of Wilms Tumor

MR Tumor Staging for Treatment Decision in Case of Wilms Tumor MR Tumor Staging for Treatment Decision in Case of Wilms Tumor G. Schneider, M.D., Ph.D.; P. Fries, M.D. Dept. of Diagnostic and Interventional Radiology, Saarland University Hospital, Homburg/Saar, Germany

More information

Diffusion Weighted Imaging in Prostate Cancer

Diffusion Weighted Imaging in Prostate Cancer Diffusion Weighted Imaging in Prostate Cancer Disclosure Information Vikas Kundra, M.D, Ph.D. No financial relationships to disclose. Education Goals and Objectives To describe the utility of diffusion-weighted

More information

Jeffrey C. Weinreb, MD, FACR Yale School of Medicine Yale-New Haven Hospital

Jeffrey C. Weinreb, MD, FACR Yale School of Medicine Yale-New Haven Hospital Jeffrey C. Weinreb, MD, FACR Yale School of Medicine Yale-New Haven Hospital jeffrey.weinreb@yale.edu 1991 1997 Whole body MRI: multistation approach x z Isocenter: Table Move: Multiple Steps Whole body

More information

F NaF PET/CT in the Evaluation of Skeletal Malignancy

F NaF PET/CT in the Evaluation of Skeletal Malignancy F NaF PET/CT in the Evaluation of Skeletal Malignancy Andrei Iagaru, MD September 26, 2013 School of of Medicine Ø Introduction Ø F NaF PET/CT in Primary Bone Cancers Ø F NaF PET/CT in Bone Metastases

More information

Update on RECIST and Staging of Common Pediatric Tumors Ethan A. Smith, MD

Update on RECIST and Staging of Common Pediatric Tumors Ethan A. Smith, MD Update on RECIST and Staging of Common Pediatric Tumors Ethan A. Smith, MD Section of Pediatric Radiology C.S. Mott Children s Hospital University of Michigan ethans@med.umich.edu Disclosures No relevant

More information

Ryan Niederkohr, M.D. Slides are not to be reproduced without permission of author

Ryan Niederkohr, M.D. Slides are not to be reproduced without permission of author Ryan Niederkohr, M.D. CMS: PET/CT CPT CODES 78814 Limited Area (e.g., head/neck only; chest only) 78815 78816 Regional (skull base to mid-thighs) True Whole Body (skull vertex to feet) SELECTING FIELD

More information

Whole body Diffusion Weighted MRI (WB-DWI) in the assessment and treatment response of multiple myeloma (MM).

Whole body Diffusion Weighted MRI (WB-DWI) in the assessment and treatment response of multiple myeloma (MM). Whole body Diffusion Weighted MRI (WB-DWI) in the assessment and treatment response of multiple myeloma (MM). Poster No.: C-1467 Congress: ECR 01 Type: Educational Exhibit Authors: A. Mahatma, A. Gogbashian,

More information

Whole body MRI with DWIBS in oncology: an overview of imaging findings

Whole body MRI with DWIBS in oncology: an overview of imaging findings Whole body MRI with DWIBS in oncology: an overview of imaging findings Poster No.: C-2622 Congress: ECR 2013 Type: Educational Exhibit Authors: E. J. Boerhout, D. P. Noij, I. C. Pieters, E. F. I. Comans,

More information

Clinical Applications

Clinical Applications C H A P T E R 16 Clinical Applications In selecting pulse sequences and measurement parameters for a specific application, MRI allows the user tremendous flexibility to produce variations in contrast between

More information

Whole-body MRI using a sliding table and repositioning surface coil approach

Whole-body MRI using a sliding table and repositioning surface coil approach Eur Radiol (2010) 20: 1366 1373 DOI 10.1007/s00330-009-1674-1 MAGNETIC RESONANCE Taro Takahara Thomas Kwee Satoshi Kibune Reiji Ochiai Tetsuro Sakamoto Tetsu Niwa Marc Van Cauteren Peter Luijten Whole-body

More information

High Resolution T2-Weighted Dixon Based Whole Body Magnetic Resonance Imaging in Detecting Bone Metastasis; Initial Results

High Resolution T2-Weighted Dixon Based Whole Body Magnetic Resonance Imaging in Detecting Bone Metastasis; Initial Results Acta Medica Anatolia Volume 4 Issue 4 2016 High Resolution T2-Weighted Dixon Based Whole Body Magnetic Resonance Imaging in Detecting Bone Metastasis; Initial Results Ali Özgen 1, Nalan Alan Selçuk 2,

More information

Computed Diffusion-Weighted Image in the Abdomen

Computed Diffusion-Weighted Image in the Abdomen Computed Diffusion-Weighted Image in the Abdomen Poster No.: C-0234 Congress: ECR 2014 Type: Scientific Exhibit Authors: T. Yoshikawa 1, N. Aoyama 1, Y. Ohno 1, K. Kyotani 1, Y. Kassai 2, K. Sofue 1, M.

More information

Role of Diffusion WIs and T 2 * GRE Pulse Sequences in Dubious Vertebral Marrow Pathological Lesions

Role of Diffusion WIs and T 2 * GRE Pulse Sequences in Dubious Vertebral Marrow Pathological Lesions Journal of the Egyptian Nat. Cancer Inst., Vol. 19, No. 4, December: 254-262, 2007 Role of Diffusion WIs and T 2 * GRE Pulse Sequences in Dubious Vertebral Marrow Pathological Lesions OMAR M. OSMAN, M.D.*;

More information

Disclosure. Acknowledgement. What is the Best Workup for Rectal Cancer Staging: US/MRI/PET? Rectal cancer imaging. None

Disclosure. Acknowledgement. What is the Best Workup for Rectal Cancer Staging: US/MRI/PET? Rectal cancer imaging. None What is the Best Workup for Rectal Cancer Staging: US/MRI/PET? Zhen Jane Wang, MD Assistant Professor in Residence UC SF Department of Radiology Disclosure None Acknowledgement Hueylan Chern, MD, Department

More information

What Radiologists do?

What Radiologists do? Multimodality Imaging in Oncology 2018 March 5 th 9th Diagnostic Imaging in Oncology What Radiologists do? Chikako Suzuki, MD, PhD Department of Diagnostic Radiology, KS Solna Department of Molecular Medicine

More information

González-Sistal, A. Diagnostic Imaging Modalities of Osteoblastic Metastases. Hospital Imaging & Radiology Europe, 2 (1): (2007)

González-Sistal, A. Diagnostic Imaging Modalities of Osteoblastic Metastases. Hospital Imaging & Radiology Europe, 2 (1): (2007) Post print version: González-Sistal, A. Diagnostic Imaging Modalities of Osteoblastic Metastases. Hospital Imaging & Radiology Europe, 2 (1): 16-17 (2007) Tittle: Diagnostic imaging modalities of osteoblastic

More information

Clinical indications for positron emission tomography

Clinical indications for positron emission tomography Clinical indications for positron emission tomography Oncology applications Brain and spinal cord Parotid Suspected tumour recurrence when anatomical imaging is difficult or equivocal and management will

More information

Index. Surg Oncol Clin N Am 16 (2007) Note: Page numbers of article titles are in boldface type.

Index. Surg Oncol Clin N Am 16 (2007) Note: Page numbers of article titles are in boldface type. Surg Oncol Clin N Am 16 (2007) 465 469 Index Note: Page numbers of article titles are in boldface type. A Adjuvant therapy, preoperative for gastric cancer, staging and, 339 B Breast cancer, metabolic

More information

1 Introduction. 2 Materials and methods. LI Na 1 LI Yaming 1,* YANG Chunming 2 LI Xuena 1 YIN Yafu 1 ZHOU Jiumao 1

1 Introduction. 2 Materials and methods. LI Na 1 LI Yaming 1,* YANG Chunming 2 LI Xuena 1 YIN Yafu 1 ZHOU Jiumao 1 Nuclear Science and Techniques 20 (2009) 354 358 18 F-FDG PET/CT in diagnosis of skeletal metastases LI Na 1 LI Yaming 1,* YANG Chunming 2 LI Xuena 1 YIN Yafu 1 ZHOU Jiumao 1 1 Department of Nuclear Medicine,

More information

11/10/2015. Prostate cancer in the U.S. Multi-parametric MRI of Prostate Diagnosis and Treatment Planning. NIH estimates for 2015.

11/10/2015. Prostate cancer in the U.S. Multi-parametric MRI of Prostate Diagnosis and Treatment Planning. NIH estimates for 2015. Multi-parametric MRI of Prostate Diagnosis and Treatment Planning Temel Tirkes, M.D. Associate Professor of Radiology Director, Genitourinary Radiology Indiana University School of Medicine Department

More information

Disclosures. Diffusion and Perfusion Imaging in the Head and Neck. Learning objectives ???

Disclosures. Diffusion and Perfusion Imaging in the Head and Neck. Learning objectives ??? Disclosures No relevant financial disclosures Diffusion and Perfusion Imaging in the Head and Neck Ashok Srinivasan, MD Associate Professor Director of Neuroradiology University of Michigan Health System

More information

JMSCR Vol 05 Issue 06 Page June 2017

JMSCR Vol 05 Issue 06 Page June 2017 www.jmscr.igmpublication.org Impact Factor 5.84 Index Copernicus Value: 83.27 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v5i6.29 MRI in Clinically Suspected Uterine and

More information

tional information has been overcome by the introduction in diffusion whole body imaging (3-5). Diffusionweighted

tional information has been overcome by the introduction in diffusion whole body imaging (3-5). Diffusionweighted JBR BTR, 2014, 97: 341-345. The effectiveness of whole body magnetic resonance imaging (Diffusion-weighted imaging and fat saturated T2-weighted imaging) in the evaluation of patients with newly diagnosed

More information

Medical imaging X-ray, CT, MRI, scintigraphy, SPECT, PET Györgyi Műzes

Medical imaging X-ray, CT, MRI, scintigraphy, SPECT, PET Györgyi Műzes Medical imaging X-ray, CT, MRI, scintigraphy, SPECT, PET Györgyi Műzes Semmelweis University, 2nd Dept. of Medicine Medical imaging: definition technical process of creating visual representations about

More information

Imaging in gastric cancer

Imaging in gastric cancer Imaging in gastric cancer Gastric cancer remains a deadly disease because of late diagnosis. Adenocarcinoma represents 90% of malignant tumors. Diagnosis is based on endoscopic examination with biopsies.

More information

بسم هللا الرحمن الرحيم. Prof soha Talaat

بسم هللا الرحمن الرحيم. Prof soha Talaat بسم هللا الرحمن الرحيم Ovarian tumors The leading indication for gynecologic surgery. Preoperative characterization of complex solid and cystic adnexal masses is crucial for informing patients about possible

More information

Differentiation of osteoporosis from metastasis in the vertebral fracture using chemical shift and diffusion weighted imaging

Differentiation of osteoporosis from metastasis in the vertebral fracture using chemical shift and diffusion weighted imaging Differentiation of osteoporosis from metastasis in the vertebral fracture using chemical shift and diffusion weighted imaging Poster No.: C-0444 Congress: ECR 2012 Type: Educational Exhibit Authors: H.

More information

Whole-body-MRI with DWIBS for detecting distant metastases in patients with head and neck squamous cell carcinoma: a feasibility study

Whole-body-MRI with DWIBS for detecting distant metastases in patients with head and neck squamous cell carcinoma: a feasibility study Whole-body-MRI with DWIBS for detecting distant metastases in patients with head and neck squamous cell carcinoma: a feasibility study Poster No.: C-245 Congress: ECR 203 Type: Scientific Exhibit Authors:

More information

Whole body MR in patients with multiple myeloma

Whole body MR in patients with multiple myeloma Whole body MR in patients with multiple myeloma Alina Piekarek, Piotr Sosnowski, Adam Nowicki, Mieczysław Komarnicki Received: 11.05.2009 Accepted: 13.07.2009 Subject: original article Clinical Radiology

More information

HEALTHFIRST 2011 RADIOLOGY PROGRAM CODE LIST

HEALTHFIRST 2011 RADIOLOGY PROGRAM CODE LIST HEALTHFIRST 2011 RADIOLOGY PROGRAM CODE LIST Outpatient Radiology utilization call Carecore at 1-877-773-6964 Modality CPT CODE Description CT SCANS 70450 CT HEAD/BRAIN W/O CONTRAST CT SCANS 70460 CT HEAD/BRAIN

More information

Diffusion-weighted MR neurography for the assessment of brachial plexopathy in oncological practice

Diffusion-weighted MR neurography for the assessment of brachial plexopathy in oncological practice Andreou et al. Cancer Imaging (2015) 15:6 DOI 10.1186/s40644-015-0041-5 RESEARCH ARTICLE Open Access Diffusion-weighted MR neurography for the assessment of brachial plexopathy in oncological practice

More information

Staging Colorectal Cancer

Staging Colorectal Cancer Staging Colorectal Cancer CT is recommended as the initial staging scan for colorectal cancer to assess local extent of the disease and to look for metastases to the liver and/or lung Further imaging for

More information

Role of MRI Diffusion in Assessment of Malignant Mediastinal Masses

Role of MRI Diffusion in Assessment of Malignant Mediastinal Masses Med. J. Cairo Univ., Vol. 85, No. 4, June: 1497-1504, 2017 www.medicaljournalofcairouniversity.net Role of MRI Diffusion in Assessment of Malignant Mediastinal Masses YOUSSRIAH Y. SABRI, M.D.*; TAKEYA

More information

Nuclear Medicine: Manuals. Nuclear Medicine. Nuclear imaging. Emission imaging: study types. Bone scintigraphy - technique

Nuclear Medicine: Manuals. Nuclear Medicine. Nuclear imaging. Emission imaging: study types. Bone scintigraphy - technique Nuclear Medicine - Unsealed radioactive preparations the tracer mixes with the patients body fluids on a molecular level (e.g. after intravenous injection) - 3 main fields: - In vitro : measuring concentrations

More information

Dr Sneha Shah Tata Memorial Hospital, Mumbai.

Dr Sneha Shah Tata Memorial Hospital, Mumbai. Dr Sneha Shah Tata Memorial Hospital, Mumbai. Topics covered Lymphomas including Burkitts Pediatric solid tumors (non CNS) Musculoskeletal Ewings & osteosarcoma. Neuroblastomas Nasopharyngeal carcinomas

More information

Prostate Case Scenario 1

Prostate Case Scenario 1 Prostate Case Scenario 1 H&P 5/12/16: A 57-year-old Hispanic male presents with frequency of micturition, urinary urgency, and hesitancy associated with a weak stream. Over the past several weeks, he has

More information

Computed Tomography of Normal Adrenal Glands in Indian Population

Computed Tomography of Normal Adrenal Glands in Indian Population IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 17, Issue 01 Ver. V January. (2018), PP 26-30 www.iosrjournals.org Computed Tomography of Normal Adrenal

More information

FDG-PET/CT for cancer management

FDG-PET/CT for cancer management 195 REVIEW FDG-PET/CT for cancer management Hideki Otsuka, Naomi Morita, Kyo Yamashita, and Hiromu Nishitani Department of Radiology, Institute of Health Biosciences, The University of Tokushima, Graduate

More information

Nuclear Medicine and PET. D. J. McMahon rev cewood

Nuclear Medicine and PET. D. J. McMahon rev cewood Nuclear Medicine and PET D. J. McMahon 150504 rev cewood 2018-02-15 Key Points Nuclear Medicine and PET: Imaging: Understand how Nuc Med & PET differ from Radiography & CT by the source of radiation. Be

More information

Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology

Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology Eur Radiol (2008) 18: 1937 1952 DOI 10.1007/s00330-008-0968-z MAGNETIC RESONANCE Thomas C. Kwee Taro Takahara Reiji Ochiai Rutger A. J. Nievelstein Peter R. Luijten Diffusion-weighted whole-body imaging

More information

Optimized. clinical pathway. propels high utilization of PET/MR at Pitié-Salpêtrière Hospital

Optimized. clinical pathway. propels high utilization of PET/MR at Pitié-Salpêtrière Hospital Optimized propels high utilization of PET/MR at Pitié-Salpêtrière Hospital clinical pathway As one of Europe s largest teaching hospitals, Pitié-Salpêtrière Hospital is renowned for its innovative research

More information

Bone and CT Scans Are Complementary for Diagnoses of Bone Metastases in Breast Cancer When PET Scans Findings Are Equivocal: A Case Report

Bone and CT Scans Are Complementary for Diagnoses of Bone Metastases in Breast Cancer When PET Scans Findings Are Equivocal: A Case Report Bone and CT Scans Are Complementary for Diagnoses of Bone Metastases in Breast Cancer When Scans Findings Are Equivocal: A Case Report Yuk-Wah Tsang 1, Jyh-Gang Leu 2, Yen-Kung Chen 3, Kwan-Hwa Chi 1,4

More information

THE ADVANTAGES OF bone scintigraphy for patients with

THE ADVANTAGES OF bone scintigraphy for patients with CLINICAL NUCLEAR MEDICINE Volume 27, Number 8, pp 567 571 2002, Lippincott Williams & Wilkins, Inc. Clinical Significance of Solitary Rib Hot Spots on Bone Scans in Patients with Extraskeletal Cancer Correlation

More information

RECENT ADVANCES IN CLINICAL MR OF ARTICULAR CARTILAGE

RECENT ADVANCES IN CLINICAL MR OF ARTICULAR CARTILAGE In Practice RECENT ADVANCES IN CLINICAL MR OF ARTICULAR CARTILAGE By Atsuya Watanabe, MD, PhD, Director, Advanced Diagnostic Imaging Center and Associate Professor, Department of Orthopedic Surgery, Teikyo

More information

University of Groningen

University of Groningen University of Groningen Can FDG-PET/CT replace blind bone marrow biopsy of the posterior iliac crest in Ewing sarcoma? Kasalak, Omer; Glaudemans, Andor W.J.M.; Overbosch, Jelle; Jutte, Paul C.; Kwee, Thomas

More information

objectives Pitfalls and Pearls in PET/CT imaging Kevin Robinson, DO Assistant Professor Department of Radiology Michigan State University

objectives Pitfalls and Pearls in PET/CT imaging Kevin Robinson, DO Assistant Professor Department of Radiology Michigan State University objectives Pitfalls and Pearls in PET/CT imaging Kevin Robinson, DO Assistant Professor Department of Radiology Michigan State University To determine the regions of physiologic activity To understand

More information

SELF-ASSESSMENT MODULE REFERENCE SPR 2018 Oncologic Imaging Course Adrenal Tumors November 10, :00 12:10 p.m.

SELF-ASSESSMENT MODULE REFERENCE SPR 2018 Oncologic Imaging Course Adrenal Tumors November 10, :00 12:10 p.m. SELF-ASSESSMENT MODULE REFERENCE SPR 2018 Oncologic Imaging Course Adrenal Tumors November 10, 2018 10:00 12:10 p.m. Staging Susan E. Sharp, MD 1. In the International Neuroblastoma Risk Group Staging

More information

A 64 y.o. man presents to the hospital with persistent cough and hemoptysis. Fernando Mut Montevideo - Uruguay

A 64 y.o. man presents to the hospital with persistent cough and hemoptysis. Fernando Mut Montevideo - Uruguay A 64 y.o. man presents to the hospital with persistent cough and hemoptysis Fernando Mut Montevideo - Uruguay Teaching case Bone # 1 A 64 y.o. man presents to the hospital with persistent cough and hemoptysis.

More information

Anyone can get breast cancer BREAST MRI BREAST CANCER. The incidence of getting breast cancer is 1:19 in Malaysia

Anyone can get breast cancer BREAST MRI BREAST CANCER. The incidence of getting breast cancer is 1:19 in Malaysia Anyone can get breast cancer BREAST MRI KATE Datin Dr Fatimah Moosa Sunway Medical Centre DATIN SERI ENDON KYLIE SIZE DOES NOT MAKE A DIFFERENCE BREAST CANCER The incidence of getting breast cancer is

More information

Whole-Body Diffusion-Weighted MRI Compared With 18 F-NaF PET/CT for Detection of Bone Metastases in Patients With High-Risk Prostate Carcinoma

Whole-Body Diffusion-Weighted MRI Compared With 18 F-NaF PET/CT for Detection of Bone Metastases in Patients With High-Risk Prostate Carcinoma Nuclear Medicine and Molecular Imaging Original Research Mosavi et al. Imaging Bone Metastases in Prostate Carcinoma Nuclear Medicine and Molecular Imaging Original Research Firas Mosavi 1 Silvia Johansson

More information

MRI and CT Evaluation of Primary Bone and Soft- Tissue Tumors

MRI and CT Evaluation of Primary Bone and Soft- Tissue Tumors 749 Alex M. Aisen1 William Martel1 Ethan M. Braunstein1 Kim I. McMillin1 William A. Phillips2 Thomas F. KIing2 Received June 10, 1985; accepted after revision December 23, 1985. Presented at the annu meeting

More information

Principles of nuclear metabolic imaging. Prof. Dr. Alex Maes AZ Groeninge Kortrijk and KULeuven Belgium

Principles of nuclear metabolic imaging. Prof. Dr. Alex Maes AZ Groeninge Kortrijk and KULeuven Belgium Principles of nuclear metabolic imaging Prof. Dr. Alex Maes AZ Groeninge Kortrijk and KULeuven Belgium I. Molecular imaging probes A. Introduction - Chemical disturbances will precede anatomical abnormalities

More information

Imaging Choices in Occult Hip Fracture

Imaging Choices in Occult Hip Fracture Introduction Imaging Choices in Occult Hip Fracture Jesse Cannon, MD; Salvatore Silvestri, MD; Mark Munro, MD J Emerg Med. 2009;32(3):144-152 Reporter PGY 宋兆家 Supervisor VS 侯勝文 990220 High dependence on

More information

Using PET/CT in Prostate Cancer

Using PET/CT in Prostate Cancer Using PET/CT in Prostate Cancer Legal Disclaimer These materials were prepared in good faith by MITA as a service to the profession and are believed to be reliable based on current scientific literature.

More information

Role of positron emission mammography (PEM) for assessment of axillary lymph node status in patients with breast cancer

Role of positron emission mammography (PEM) for assessment of axillary lymph node status in patients with breast cancer Role of positron emission mammography (PEM) for assessment of axillary lymph node status in patients with breast cancer Poster No.: C-1260 Congress: ECR 2011 Type: Scientific Paper Authors: K. M. Kulkarni,

More information

Management of a Solitary Bone Metastasis to the Tibia from Colorectal Cancer

Management of a Solitary Bone Metastasis to the Tibia from Colorectal Cancer 354 Management of a Solitary Bone Metastasis to the Tibia from Colorectal Cancer Anastasia S. Chalkidou a Panagiotis Padelis a Anastasios L. Boutis b a Clinical Oncology Department, Theagenion Cancer Hospital

More information

Diffusion-weighted MR Imaging Offers No Advantage over Routine Noncontrast MR Imaging in the Detection of Vertebral Metastases

Diffusion-weighted MR Imaging Offers No Advantage over Routine Noncontrast MR Imaging in the Detection of Vertebral Metastases AJNR Am J Neuroradiol 1:948 953, May Diffusion-weighted MR Imaging Offers No Advantage over Routine Noncontrast MR Imaging in the Detection of Vertebral Metastases Mauricio Castillo, Andres Arbelaez, J.

More information

MAGNETOM Aera Combining Throughput and Highest Quality Spine Imaging in an Optimized Clinical Workflow

MAGNETOM Aera Combining Throughput and Highest Quality Spine Imaging in an Optimized Clinical Workflow Clinical Orthopedic Imaging MAGNETOM Aera Combining Throughput and Highest Quality Spine Imaging in an Optimized Clinical Workflow Johan Dehem, M.D. VZW Jan Yperman, Ieper, Belgium Cervical spine imaging

More information

Whole body F-18 sodium fluoride PET/CT in the detection of bone metastases in patients with known malignancies: A pictorial review

Whole body F-18 sodium fluoride PET/CT in the detection of bone metastases in patients with known malignancies: A pictorial review Whole body F-18 sodium fluoride PET/CT in the detection of bone metastases in patients with known malignancies: A pictorial review Poster No.: C-1196 Congress: ECR 2014 Type: Educational Exhibit Authors:

More information

FDG-PET value in deep endometriosis

FDG-PET value in deep endometriosis Gynecol Surg (2011) 8:305 309 DOI 10.1007/s10397-010-0652-6 ORIGINAL ARTICLE FDG-PET value in deep endometriosis A. Setubal & S. Maia & C. Lowenthal & Z. Sidiropoulou Received: 3 December 2010 / Accepted:

More information

MRI-PET: Oncologic Applications

MRI-PET: Oncologic Applications MRI-PET: Oncologic Applications Pablo R. Ros, MD University Hospitals Case Medical Center Case Western Reserve University SCBT-MR Boston, MA October, 2012 Pablo.Ros@UHhospitals.org Acknowledgement Osman

More information

Anatomical and Functional MRI of the Pancreas

Anatomical and Functional MRI of the Pancreas Anatomical and Functional MRI of the Pancreas MA Bali, MD, T Metens, PhD Erasme Hospital Free University of Brussels Belgium mbali@ulb.ac.be Introduction The use of MRI to investigate the pancreas has

More information

Institution INSTRUCTIONS (I6) 1. This form is to be completed by a DESIGNATED STUDY NUCLEAR MEDICINE SPECIALIST

Institution INSTRUCTIONS (I6) 1. This form is to be completed by a DESIGNATED STUDY NUCLEAR MEDICINE SPECIALIST I6 ACRIN 6660 Whole Body MRI in the Evaluation of Pediatric Malignancies Conventional Scintigraphy Imaging Form If this is a revised or corrected form, indicate by checking box and fax to 215-717 - 0936.

More information

Hybrid bone scintigraphy in gastrointestinal malignancies Institutional Experience

Hybrid bone scintigraphy in gastrointestinal malignancies Institutional Experience Hybrid bone scintigraphy in gastrointestinal malignancies Institutional Experience Nazia Rashid 1, Saima Riaz 1, Humayun Bashir 1, Shafqat Mehmood 2 1 Nuclear Medicine Department ad 2 Internal Medicine

More information

FDG PET/CT STAGING OF LUNG CANCER. Dr Shakher Ramdave

FDG PET/CT STAGING OF LUNG CANCER. Dr Shakher Ramdave FDG PET/CT STAGING OF LUNG CANCER Dr Shakher Ramdave FDG PET/CT STAGING OF LUNG CANCER FDG PET/CT is used in all patients with lung cancer who are considered for curative treatment to exclude occult disease.

More information

performed to help sway the clinician in what the appropriate diagnosis is, which can substantially alter the treatment of management.

performed to help sway the clinician in what the appropriate diagnosis is, which can substantially alter the treatment of management. Hello, I am Maura Polansky at the University of Texas MD Anderson Cancer Center. I am a Physician Assistant in the Department of Gastrointestinal Medical Oncology and the Program Director for Physician

More information

Laura Tormoehlen, M.D. Neurology and EM-Toxicology Indiana University

Laura Tormoehlen, M.D. Neurology and EM-Toxicology Indiana University Laura Tormoehlen, M.D. Neurology and EM-Toxicology Indiana University Disclosures! No conflicts of interest to disclose Neuroimaging 101! Plain films! Computed tomography " Angiography " Perfusion! Magnetic

More information

SPECT/CT in Endocrine Diseases and Dosimetry

SPECT/CT in Endocrine Diseases and Dosimetry SPECT/CT in Endocrine Diseases and Dosimetry Heather A. Jacene, MD Division of Nuclear Medicine Russell H. Morgan Dept. of Radiology and Radiological Science Johns Hopkins University Baltimore, MD Disclosures

More information

PET imaging of cancer metabolism is commonly performed with F18

PET imaging of cancer metabolism is commonly performed with F18 PCRI Insights, August 2012, Vol. 15: No. 3 Carbon-11-Acetate PET/CT Imaging in Prostate Cancer Fabio Almeida, M.D. Medical Director, Arizona Molecular Imaging Center - Phoenix PET imaging of cancer metabolism

More information

Unusual Osteoblastic Secondary Lesion as Predominant Metastatic Disease Spread in Two Cases of Uterine Leiomyosarcoma

Unusual Osteoblastic Secondary Lesion as Predominant Metastatic Disease Spread in Two Cases of Uterine Leiomyosarcoma 49 Unusual Osteoblastic Secondary Lesion as Predominant Metastatic Disease Spread in Two Cases of Uterine Leiomyosarcoma Loredana Miglietta a Maria Angela Parodi b Luciano Canobbio b Luca Anselmi c a Medical

More information

Research Article Prevalence of Clinically Significant Extraosseous Findings on Unenhanced CT Portions of 18 F-Fluoride PET/CT Bone Scans

Research Article Prevalence of Clinically Significant Extraosseous Findings on Unenhanced CT Portions of 18 F-Fluoride PET/CT Bone Scans The Scientific World Journal Volume 2012, Article ID 979867, 5 pages doi:10.1100/2012/979867 The cientificworldjournal Research Article Prevalence of Clinically Significant Extraosseous Findings on Unenhanced

More information

Potential Pitfalls in Chest Diffusion Weighted Imaging

Potential Pitfalls in Chest Diffusion Weighted Imaging Potential Pitfalls in Chest Diffusion Weighted Imaging Yasuyuki Kurihara Masaki Matsusako Ryo Miyazawa Takeshi Wada Jay Starkey Department of Radiology, St. Luke s International Hospital The authors have

More information

Recommendations for cross-sectional imaging in cancer management, Second edition

Recommendations for cross-sectional imaging in cancer management, Second edition www.rcr.ac.uk Recommendations for cross-sectional imaging in cancer management, Second edition Renal and adrenal tumours Faculty of Clinical Radiology www.rcr.ac.uk Contents Renal cell carcinoma 3 Clinical

More information

Pitfalls in Oncologic Diagnosis with PET CT. Nononcologic Hypermetabolic Findings

Pitfalls in Oncologic Diagnosis with PET CT. Nononcologic Hypermetabolic Findings Pitfalls in Oncologic Diagnosis with PET CT. Nononcologic Hypermetabolic Findings Poster No.: C-1359 Congress: ECR 2012 Type: Educational Exhibit Authors: J. Rossi 1, C. A. Mariluis 1, E. Delgado 1, R.

More information

Silvia Capuani*, Giulia Di Pietro*, Guglielmo Manenti, Umberto Tarantino^

Silvia Capuani*, Giulia Di Pietro*, Guglielmo Manenti, Umberto Tarantino^ Silvia Capuani*, Giulia Di Pietro*, Guglielmo Manenti, Umberto Tarantino^ *CNR ISC, Physics Department Sapienza University, Rome, Italy Department of Diagnostic Imaging and Interventional Radiology, Molecular

More information

PET/CT Frequently Asked Questions

PET/CT Frequently Asked Questions PET/CT Frequently Asked Questions General Q: Is FDG PET specific for cancer? A: No, it is a marker of metabolism. In general, any disease that causes increased metabolism can result in increased FDG uptake

More information

HIP RADIOLOGY PROGRAM CODE LISTS

HIP RADIOLOGY PROGRAM CODE LISTS EFFECTIVE OCTOBER 1, 2012 70336 MAGNETIC RESONANCE IMAGING TMJ 70450 COMPUTED TOMOGRAPHY HEAD/BRAIN WITHOUT 70460 COMPUTED TOMOGRAPHY HEAD/BRAIN WITH 70470 COMPUTED TOMOGRAPHY HEAD/BRAIN WITHOUT AND WITH

More information

Emerging Techniques in Breast Imaging: Contrast-Enhanced Mammography and Fast MRI

Emerging Techniques in Breast Imaging: Contrast-Enhanced Mammography and Fast MRI Emerging Techniques in Breast Imaging: Contrast-Enhanced Mammography and Fast MRI Lilian Wang, M.D. Breast Imaging Section Department of Radiology Northwestern Medicine Overview Rationale for new imaging

More information

Diffusion weighted MRI in evaluation of transplanted kidney: Preliminary clinical experience

Diffusion weighted MRI in evaluation of transplanted kidney: Preliminary clinical experience African Journal of Nephrology (2009) 13: 26-30 Original Article AJN Diffusion weighted MRI in evaluation of transplanted kidney: Preliminary clinical experience Mohamed Abou El-Ghar; M.D, Huda Refaie;

More information

REVIEW. Distinguishing benign from malignant adrenal masses

REVIEW. Distinguishing benign from malignant adrenal masses Cancer Imaging (2003) 3, 102 110 DOI: 10.1102/1470-7330.2003.0006 CI REVIEW Distinguishing benign from malignant adrenal masses Isaac R Francis Professor of Radiology, Department of Radiology, University

More information

imri 2017;21:

imri 2017;21: pissn 2384-1095 eissn 2384-1109 imri 2017;21:154-161 https://doi.org/10.13104/imri.2017.21.3.154 Diagnostic Performance of Diffusion- Weighted Steady-State Free Precession in Differential Diagnosis of

More information

Cigna - Prior Authorization Procedure List: Radiology & Cardiology

Cigna - Prior Authorization Procedure List: Radiology & Cardiology Cigna - Prior Authorization Procedure List: Radiology & Cardiology Product Category CPT Code CPT Code Description Radiology MR 70336 MRI Temporomandibular Joint(s), (TMJ) Radiology CT 70450 CT Head or

More information